A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

The X Games is enlisting Google Cloud for AI judging around the Superpipe competition in this week’s X Games Aspen 2025.

We are firmly in the artificial intelligence (AI) era. What began as a niche field of research is quickly transforming how we ...

(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today released the findings of their 2024 U.S. state and local End-of-Year Rates and Rules Report. It ...

This means that since Q3 of 2023, the company has added only 589 customers in total: but excluding acquisitions, this count is only 15 customers. The question for investors now is: is Vertex truly ...

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Piper Sandler lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $533 from $535 and keeps an Overweight rating on the shares ahead of earnings. With biotech having largely ...

Vertex Pharmaceuticals' suzetrigine showed lackluster Phase II results, but I still see potential in the non-addictive pain management market given the opioid crisis. Vertex's dominance in the ...

Tourism contributed 8.6% to the Philippines' GDP in 2023, demonstrating its significance to the national economy. According ...

Orphan Drugs Market Orphan Drugs Market Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The "Orphan Drugs - Global Strategic ...

Google might have just invested another billion dollars into Anthropic, who is one of the main rivals of OpenAI.